1st Edition

Molecular Recognition in Pharmacology

By Mikhail Darkhovskiy Copyright 2024
204 Pages 4 Color & 97 B/W Illustrations
by CRC Press

204 Pages 4 Color & 97 B/W Illustrations
by CRC Press

204 Pages 4 Color & 97 B/W Illustrations
by CRC Press

This unique volume traces the behavior of the drug substance, starting from the initial pre-contact stage, and ending with the formation of the complex. Molecular recognition lies in the foundation of every life form and includes many mysteries. Currently, studies on this topic in pharmacology are limited to determining the properties of complexes of medicinal substances (drugs) with specific... Read more

Chapter 1 Energy of Intermolecular Interactions in Drug-Receptor Complex Formation


Chapter 2
Methods for Studying Drug-Receptor Binding


Chapter 3
Methods for Drug Discovery Research


Chapter 4
Thermodynamics of Drug-Receptor Complex Formation
 

Chapter 5 Effect of conformation entropy on affinity of specific ligands


Chapter 6
Kinetics of Drug-Receptor Complex Formation


Chapter 7
Distant and Contact Interactions of Drugs with Specific and Non-specific Receptors


Chapter 8
Influence of bound water on interaction of the chemical groups in drugs and receptors


Chapter 9
Information Required for Receptor Recognition


Chapter 10
Agonists and Antagonists


Chapter 11.
Non-selective Drugs


Chapter 12
Search Paths for Novel Therapeutics

Biography

Mikhail Borisovich Darkhovskiy graduated from Moscow State University in 1996 with a major in Quantum Chemistry. In 2005 he earned a PhD in Chemistry and Solid-State Physics under the supervision of Dr. Andrei Thougreeff. His research was in electronic structure and transformation of spin- isomers of iron and cobalt complexes in spin transitions using the QM/ MM effective crystal field method. Together with Professor Dukhovich, he investigated the factors involved in molecular recognition in “ligand–receptor” systems, the influence of water on complex strength, and conformational entropy as a hidden factor for complex formation. Currently, he works in the biotech startup InterX (a subsidiary of NeoTX company), participating in the development of methods for the accurate prediction of compounds’ binding affinity to proteins. His awards include the INTAS Young Scientist award, and, Emory University Visiting Scientist award (Cherry L. Emerson Center for Scientific Computation Fellowship).